
Dec 23 (Reuters) - South Korean satellite launch company Innospace on Monday launched the first commercial rocket from Brazil's Alcantara Space Center, a milestone for the firm and Brazilian aerospace ambitions that ended with a crash.
The HANBIT-Nano vehicle lifted off at 10:13 p.m. Brazil time (0113 GMT), five days later than originally scheduled.
Just two minutes after the launch, a live feed within the official livestream showed a message noting an "anomaly" was experienced during the flight. The livestream ended immediately afterward.
According to Brazil's air force, the rocket began its vertical trajectory as planned, but an issue prompted a crash into the ground. Officials and firefighters were sent to analyse the wreckage and the collision area, the air force added in a statement.
Innospace has not provided further information about the launch and did not immediately respond to a request for comment.
The firm's South Korea-listed shares fell about 24% in midday trading after the crash, the biggest intraday decline since August.
The launch was delayed from Wednesday after an anomaly in a cooling unit component of the first-stage oxidizer feed system during final inspections, and again on Friday for a few hours due to unfavourable weather conditions.
In a previous statement, Innospace said it replaced the component on the launch pad, allowing the Spaceward mission to proceed within its December 16-22 launch window. It was launching eight registered cargoes, including five small satellites, for undisclosed customers.
The Brazilian air force and space agency offered operational support for the launch in coordination with key agencies.
In March 2023, Innospace had launched its test vehicle HANBIT-TLV from the same facility in northeast Brazil to verify the performance of its 150 kN hybrid rocket engine.
(Reporting by Fernando Cardoso; Editing by Jamie Freed)
LATEST POSTS
- 1
Tzrifin base exhibition reveals Hamas and Hezbollah arms, showing structure behind attacks - 2
Watch This Glacier Race into the Sea - 3
US FDA investigates Takeda's blood disorder drug after pediatric death - 4
Go on A Careful spending plan: Modest Objections for Your List of must-dos - 5
Step by step instructions to Look at Compact disc Rates: A Thorough Aide
Investigating Free Cell Phones: What You Really want to Be aware
German police 'cleared path for fascists with batons,' protesters say
The Best 10 Innovation Developments of the Year
Extraordinary Guinness World Records That Will Astound You
Figure out How to Augment Your Rooftop Substitution Speculation
The Response to Independence from the rat race: Methodologies for Creating Financial momentum
Picking the Right Home Machines: A Commonsense Aide
How will the universe end?
BravoCon 2025: How to watch, full schedule and lineup, where to stream free and more













